„As a Heidelberg based biopharmaceutical drug development company, we are glad to have a partner like Celonic accompanying us throughout preclinical analytics and therapeutic protein production up to clinical phase I right now. We appreciate Celonic’s technologies and know-how, the trustiness and flexibility of our first choice CMO.”
Dr. Harald Fricke
Chief Medical and Operating Officer, Apogenix
"We have a long-term co-operation with Celonic.That makes sense: We are complementing each other ideally. For instance, hameln rds offers preclinical studies and clinical phase I studies from whom Celonic's customers can profit from. As a mid-sized German company offering services in health care, we support our partner Celonic in regulatory issues as well as in marketing. On the other hand, we are delighted to involve Celonic's expertise in biopharmaceutical product development. Our aim is to continuously develop ourselves and our facility in Modra (Slowakia) further."
Detlef Lürig
Managing Director, hameln rds gmbH

Frankfurt, 22-23 September 2010
Juelich receives GMP certificate

Challenging positions in development, production, downstream processing and quality control